Richard Paul Bryce

SR VP, CLINICAL RESEARCH & DEV, Puma Biotechnology.

Companies

enGene Therapeutics Inc.Chief Medical Officer Oct 31, 2023 to Dec 4, 2023¹
Rain Oncology Inc.Chief Medical Officer Apr 22, 2021 to Feb 17, 2023²
Puma BiotechnologySR VP, CLINICAL RESEARCH & DEV Jun 28, 2012 to Apr 6, 2021³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARenGene Therapeutics Inc., Chief Medical Officer
2
SEC EDGARRain Oncology Inc., Chief Medical Officer
3
SEC EDGARPuma Biotechnology, SR VP, CLINICAL RESEARCH & DEV